Amyloidosis

Amyloidosis and the heart: a comprehensive review.
[17000935] Arch Intern Med 166(17): 1805-13 (2006)

The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies.
[14746554] J Intern Med 255(2): 159-78 (2004)

Diagnostic and therapeutic approach of systemic amyloidosis.
[15255082] Neth J Med 62(4): 121-8 (2004)

Therapeutic options in systemic AL amyloidosis.
[15255079] Neth J Med 62(4): 106-13 (2004)

Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?
[12067222] J Neurochem 81(1): 1-8 (2002)

Preventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.
[19090993] BMC Neurosci 9 Suppl 2(): S5 (2008)

Selective amyloid-beta lowering agents.
[19090992] BMC Neurosci 9 Suppl 2(): S4 (2008)

Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
[8038017] Br Heart J 70(2): 111-5 (1993)

C-reactive protein (CRP)-lowering agents.
[16939632] Cardiovasc Drug Rev 24(1): 33-50 (2006)

Nodular amyloidosis: review and long-term follow-up of 16 cases.
[12975157] Arch Dermatol 139(9): 1157-9 (2003)

Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis.
[15748546] Dermatol Online J 11(1): 5 (2005)

3D domain swapping, protein oligomerization, and amyloid formation.
[11995994] Acta Biochim Pol 48(4): 807-27 (2001)

Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.
[18075673] Mol Biosyst 4(1): 42-52 (2008)

Pathogenesis, diagnosis and treatment of systemic amyloidosis.
[11260801] Philos Trans R Soc Lond B Biol Sci 356(1406): 203-10; discussion 210-1 (2001)

The structural basis of protein folding and its links with human disease.
[11260793] Philos Trans R Soc Lond B Biol Sci 356(1406): 133-45 (2001)

Mechanism of amyloidogenesis: nucleation-dependent fibrillation versus double-concerted fibrillation.
[19788854] BMB Rep 42(9): 541-51 (2009)

Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease.
[16233815] J Biosci Bioeng 99(5): 437-47 (2005)

Musculoskeletal manifestations of amyloidosis. A review of 83 patients on haemodialysis for at least 10 years.
[2005153] J Bone Joint Surg Br 73(2): 271-6 (1991)

Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy.
[18363891] Aliment Pharmacol Ther 27(11): 1006-16 (2008)

Amyloidosis: is a cure possible?
[18519408] Ann Oncol 19 Suppl 4(): iv63-6 (2008)

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.
[16044444] Am J Hematol 79(4): 319-28 (2005)

Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease.
[12135474] Eur J Biochem 269(14): 3362-71 (2002)

Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool.
[16302962] FEBS J 272(23): 5971-8 (2005)

The Yin and Yang of protein folding.
[16302961] FEBS J 272(23): 5962-70 (2005)

Structures for amyloid fibrils.
[16302960] FEBS J 272(23): 5950-61 (2005)

Aspects on human amyloid forms and their fibril polypeptides.
[16302959] FEBS J 272(23): 5942-9 (2005)

Glimpses of the molecular mechanisms of beta2-microglobulin fibril formation in vitro: aggregation on a complex energy landscape.
[19433089] FEBS Lett 583(16): 2623-9 (2009)

Structural classification of toxic amyloid oligomers.
[18723507] J Biol Chem 283(44): 29639-43 (2008)

The AbetaCs of Abeta-cleaving proteases.
[18723506] J Biol Chem 283(44): 29645-9 (2008)

The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology.
[18650431] J Biol Chem 283(44): 29621-5 (2008)

Amyloid precursor protein trafficking, processing, and function.
[18650430] J Biol Chem 283(44): 29615-9 (2008)

Structural polymorphism of Alzheimer Abeta and other amyloid fibrils.
[19597329] Prion 3(2): 89-93 (2009)

The multiple mechanisms of amyloid deposition: the role of parkin.
[19270506] Prion 3(1): 5-11 (2009)

Amyloid fibrils: abnormal protein assembly.
[19158505] Prion 2(3): 112-7 (2008)

Computational simulations of the early steps of protein aggregation.
[19164927] Prion 1(1): 3-8 (2007)

Hacking the code of amyloid formation: the amyloid stretch hypothesis.
[19164912] Prion 1(1): 9-14 (2007)

Unzipping the mysteries of amyloid fiber formation.
[15070716] Proc Natl Acad Sci U S A 101(13): 4335-6 (2004)

Polychlorinated biphenyls inhibit amyloid fibril formation.
[15610843] Chem Biol 11(12): 1604-6 (2004)

Transthyretin amyloidosis: a tale of weak interactions.
[11412857] FEBS Lett 498(2-3): 201-3 (2001)

Ideas of order for amyloid fibril structure.
[12176381] Structure 10(8): 1031-6 (2002)

Amyloid fibril formation and protein misassembly: a structural quest for insights into amyloid and prion diseases.
[9195890] Structure 5(5): 595-600 (1997)

The classification and typing of amyloid deposits.
[15198347] Am J Clin Pathol 121(6): 787-9 (2004)

The pathogenesis of amyloidosis: understanding general principles.
[9588878] Am J Pathol 152(5): 1125-7 (1998)

Leptomeningeal amyloid and variant transthyretins.
[8579096] Am J Pathol 148(2): 351-4 (1996)

Pulmonary amyloidosis. The Mayo Clinic experience from 1980 to 1993.
[8554249] Ann Intern Med 124(4): 407-13 (1996)

Transthyretin-related familial amyloidotic polyneuropathy.
[16009758] Arch Neurol 62(7): 1057-62 (2005)

Long-term survival (10 years or more) in 30 patients with primary amyloidosis.
[9920856] Blood 93(3): 1062-6 (1999)

Amyloidosis: a final common pathway for protein deposition in tissues.
[2137018] Blood 75(3): 531-45 (1990)

Editorial: Newer concepts in amyloidogenesis.
[1268771] Can Med Assoc J 114(10): 872-3 (1976)

Renal amyloidosis: a review of 12 cases.
[13894754] Can Med Assoc J 85(-): 967-73 (1961)

Diagnosis and management of the cardiac amyloidoses.
[16186440] Circulation 112(13): 2047-60 (2005)

Light-chain (AL) amyloidosis: diagnosis and treatment.
[17699366] Clin J Am Soc Nephrol 1(6): 1331-41 (2006)

Current treatment of AL amyloidosis.
[19644136] Haematologica 94(8): 1044-8 (2009)

Cardiac amyloidosis: heterogenous pathogenic backgrounds.
[15645642] Intern Med 43(12): 1107-14 (2004)

Amyloidosis-associated kidney disease.
[17093068] J Am Soc Nephrol 17(12): 3458-71 (2006)

Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.
[15292279] J Clin Endocrinol Metab 89(8): 3629-43 (2004)

Amyloid in the cardiovascular system: a review.
[15677530] J Clin Pathol 58(2): 125-33 (2005)

Primary amyloidosis: a review.
[13357618] J Clin Pathol 9(3): 187-211 (1956)

Inherited amyloidosis.
[1848299] J Med Genet 28(2): 73-8 (1991)

Genetic factors in amyloidosis.
[176361] J Med Genet 12(4): 317-26 (1975)

Diagnosing primary amyloidosis.
[12479511] Mayo Clin Proc 77(12): 1278-9 (2002)

Cerebral amyloid angiopathy. A critical review.
[3551211] Stroke 18(2): 311-24 (1987)

Cerebral amyloid angiopathy presenting as a mass lesion.
[3810758] Stroke 18(1): 234-9 (1987)

Molecular determinants for amyloid fibril formation: lessons from lung surfactant protein C.
[12844270] Swiss Med Wkly 133(19-20): 275-82 (2003)

Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.
[16107109] Tex Heart Inst J 32(2): 178-84 (2005)

Amyloid and the lower respiratory tract.
[6344311] Thorax 38(2): 84-7 (1983)

Evaluation and management of the cardiac amyloidosis.
[18036445] J Am Coll Cardiol 50(22): 2101-10 (2007)

Dialysis-related amyloidosis revisited.
[16303998] AJR Am J Roentgenol 185(6): 1460-7 (2005)

Use of eINDs for evaluation of multiple related PET amyloid plaque imaging agents.
[18511825] J Nucl Med 49(6): 47N-48N (2008)

Uptake of technetium-99m MDP in primary amyloidosis with a review of the mechanisms of soft tissue localization of bone seeking radiopharmaceuticals.
[8355083] J Nucl Med 34(9): 1612-5 (1993)

[BIG-H3 protein: mutation of codon 124 and corneal amyloidosis].
[15179309] J Fr Ophtalmol 27(5): 510-22 (2004)

Amyloidosis: review and CT manifestations.
[15026589] Radiographics 24(2): 405-16 (2004)

CT evaluation of amyloidosis: spectrum of disease.
[8290725] Radiographics 13(6): 1295-308 (1993)

MRI assessment of cardiac amyloidosis: experience of six cases with review of the current literature.
[19029219] Br J Radiol 82(976): 337-42 (2009)

Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses.
[20133122] Curr Opin Struct Biol 20(1): 54-62 (2010)

Principles governing oligomer formation in amyloidogenic peptides.
[20106655] Curr Opin Struct Biol 20(2): 187-95 (2010)

Molecular mechanism of Thioflavin-T binding to amyloid fibrils.
[20399286] Biochim Biophys Acta 1804(7): 1405-12 (2010)

Patterns of neuropathy and autonomic failure in patients with amyloidosis.
[18990321] Mayo Clin Proc 83(11): 1226-30 (2008)

Modern treatment of amyloidosis: unresolved questions.
[19073820] J Am Soc Nephrol 20(3): 469-72 (2009)

Recent insights into the pathogenesis of type AA amyloidosis.
[21403980] ScientificWorldJournal 11(-): 641-50 (2011)

How I treat amyloidosis.
[19617578] Blood 114(15): 3147-57 (2009)

Bortezomib in the treatment of AL amyloidosis: targeted therapy?
[18024367] Haematologica 92(10): 1302-7 (2007)

Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy.
[21239808] Hematology Am Soc Hematol Educ Program 2010(-): 287-94 (2010)

Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.
[18470479] Cell Mol Life Sci 65(16): 2574-85 (2008)

Beta arcades: recurring motifs in naturally occurring and disease-related amyloid fibrils.
[20032312] FASEB J 24(5): 1311-9 (2010)

CD36: implications in cardiovascular disease.
[17466567] Int J Biochem Cell Biol 39(11): 2012-30 (2007)

Animal models of human amyloidoses: are transgenic mice worth the time and trouble?
[19627988] FEBS Lett 583(16): 2663-73 (2009)

Cardiac nonamyloidotic immunoglobulin deposition disease.
[16341150] Mod Pathol 19(2): 233-7 (2006)

Effect of nanoparticles on protein folding and fibrillogenesis.
[19333426] Int J Mol Sci 10(2): 646-55 (2009)

Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.
[20689228] Proc Jpn Acad Ser B Phys Biol Sci 86(7): 694-706 (2010)

Mysterious oligomerization of the amyloidogenic proteins.
[20546306] FEBS J 277(14): 2940-53 (2010)

Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease.
[21358971] Curr Neuropharmacol 8(3): 211-7 (2010)

Cutaneous amyloidoses and systemic amyloidoses with cutaneous involvement.
[20071301] Eur J Dermatol 20(2): 152-60 (2010)

Cardiac amyloidosis responding to bortezomib: case report and review of literature.
[20676282] Curr Cardiol Rev 5(3): 228-36 (2009)

Structural basis of infectious and non-infectious amyloids.
[18537545] Curr Alzheimer Res 5(3): 308-18 (2008)

Amyloidogenesis of natively unfolded proteins.
[18537543] Curr Alzheimer Res 5(3): 260-87 (2008)

Polyneuropathy associated with IgA paraproteinemia and amyloidosis: a case report and literature review.
[19513304] J Clin Neurol 3(2): 116-9 (2007)

Complex polyamines: unique prion disaggregating compounds.
[19702574] CNS Neurol Disord Drug Targets 8(5): 323-8 (2009)

Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts.
[21331330] Int J Alzheimers Dis 2011(-): 906964 (2011)

Prion and nonprion amyloids: a comparison inspired by the yeast Sup35 protein.
[19164899] Prion 1(3): 179-84 (2007)

Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways.
[19421006] Prion 3(2): 51-8 (2009)

Curli provide the template for understanding controlled amyloid propagation.
[19098444] Prion 2(2): 57-60 (2008)

Functional amyloids signal their arrival.
[19622831] Sci Signal 2(80): pe43 (2009)

Domain metastability: a molecular basis for immunoglobulin deposition?
[20394753] J Mol Biol 399(2): 207-13 (2010)

Curli biogenesis and function.
[16704339] Annu Rev Microbiol 60(-): 131-47 (2006)

Solid-state NMR studies of amyloid fibril structure.
[21219138] Annu Rev Phys Chem 62(-): 279-99 (2011)

Polymerizing the fibre between bacteria and host cells: the biogenesis of functional amyloid fibres.
[18373633] Cell Microbiol 10(7): 1413-20 (2008)

A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides.
[19596696] Protein Eng Des Sel 22(8): 453-9 (2009)

Applying Hsp104 to protein-misfolding disorders.
[20130674] Biochem Cell Biol 88(1): 1-13 (2010)

Isolated cardiac involvement in primary amyloidosis: presenting as sick sinus syndrome and heart failure.
[24391340] Tex Heart Inst J 40(5):615-8 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Amyloidosis.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Amyloidosis.php on line 92